Koyfin Home > Directory > Health Care > Aeglea Biothera > EBITDA Margin

Aeglea Biothera EBITDA Margin Chart (AGLE)

Aeglea Biothera annual/quarterly EBITDA Margin from 2015 to 2018. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Aeglea Biothera EBITDA Margin for the quarter ending June 06, 2018 was $-403m a -55.84% increase of 225m year over year
  • Aeglea Biothera EBITDA Margin for the last 12 months ending March 03, 2019 was $-2,294m a 78.79% decrease of -1,808m year over year
  • Aeglea Biothera Annual EBITDA Margin for 2018 was $-1,162m a 54.64% decrease of -635m from 2017
  • Aeglea Biothera Annual EBITDA Margin for 2017 was $-527m a 10.71% decrease of -56m from 2016
  • Aeglea Biothera Annual EBITDA Margin for 2016 was $-470m a 60.79% decrease of -286m from 2015
Other Margins & Efficiency Metrics:
  • Aeglea Biothera Return on Capital % for the quarter ending September 09, 2018 was -44.64 a 29.88% decrease of -13.34 year over year
  • Aeglea Biothera Return on Equity % for the quarter ending September 09, 2018 was -69.52 a 29.52% decrease of -20.52 year over year
View Chart On Koyfin

Quarterly AGLE EBITDA Margin Data

06/2018$-403m
03/2018$-541m
12/2017$-443m
09/2017$-629m
06/2017$-450m
03/2017$-639m
12/2016$-442m
09/2016$-544m
06/2016$-398m
03/2016$-529m

Annual AGLE EBITDA Margin Data

2018$-1,162m
2017$-527m
2016$-470m
2015$-184m